Both in Pharmaceuticals
Maravai LifeSciences Holdings vs Avalyn Pharma
Over the past year MRVI returned +19.2% and AVLN returned −19.5%; their daily moves had a correlation of 0.16.
MRVI +19.2% AVLN −19.5%Growth of $1, one year, split-adjusted
| Metric | MRVI | AVLN |
|---|---|---|
| Price | $7.79 | $27.03 |
| Market cap | $1.16B | $1.20B |
| Today | +4.50% | +0.82% |
| 1 month | −0.8% | +6.3% |
| 6 months | +97.6% | — |
| Year to date | +139.5% | — |
| 1 year | +164.8% | — |
| Revenue growth (YoY) | +8.5% | — |
| Gross margin | 40.1% | — |
| Net margin | −24.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 5.6× | — |
| Net cash | -$106.6M | $337.6M |
| Dividend yield | — | — |
| Volatility (60d) | 86.4% | — |
| Short % of float | 10.7% | 11.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).